Armistice Capital, LLC, 10% Owner at AMAG PHARMACEUTICALS, INC. (AMAG), bought 72,000 shares at $8.29 ($597K) on 2020-02-25, disclosed to the SEC on 2020-02-27.
Open-market purchase of $597k AMAG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.29 | 12,000 | $99K | 16.7% |
| 2 | $8.29 | 12,000 | $99K | 16.7% |
| 3 | $8.29 | 24,000 | $199K | 33.3% |
| 4 | $8.29 | 24,000 | $199K | 33.3% |
| Total | $8.29 avg | 72,000 | $597K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |